Vitura Health (ASX:VIT)
Roy Gustini is an experienced professional currently serving as a Commercial Growth Manager at both Cortexa Pty. and Vitura Health, where responsibilities include leading a startup pharmaceutical business and contributing to mergers and acquisitions, respectively. Previous roles include extensive positions at RG Consulting, where Roy held senior leadership roles such as Acting CEO and Acting Chief Operating Officer, and at Genzyme, managing the ANZ business unit for rare diseases. Earlier experience includes serving as State Sales Manager at Aventis. Roy Gustini holds a Bachelor of Science in Pharmacology from the University of Melbourne.
This person is not in any teams
Vitura Health (ASX:VIT)
A purpose-led portfolio of companies, working to unify all aspects of the alternative and emerging therapeutics industry and bridge the gap between doctors, suppliers, pharmacists and patients. Vitura Health Limited is one of Australia’s leading emerging therapeutics groups, delivering a truly national distribution capability and the ability to service patients coast to coast across our vast country. Comprising of a number of aligned subsidiaries – Doctors on Demand, Canview, CDA Clinics, Cortexa, Cannadoc, BHC and Adaya – each brand is actively engaged in the evolution of the alternative medical sector for the better. We’re committed to providing a seamless approach to patient treatment pathways, streamlined pharmacist access to legal medications and unparalleled prescriber education, developing industry-informed clinicians. Underpinned by an innovative business model and a continuous improvement approach, Vitura Health leverages its downstream, asset-light strategy to focus on meeting the demands of this complex and growing industry. At Vitura Health, we’re focused on changing medicine and transforming lives, while continuing to generate value for our shareholders, suppliers, partners, employees and medical communities. Vitura Health Limited is listed on the ASX, under the code VIT.